U.S. pharma giant copyright scrapped two experimental weight loss drugs previous yr—a the moment-everyday pill, lotiglipron, resulting from elevated liver enzymes and a twice-everyday pill, danuglipron, as a consequence of potent Unwanted effects—but CEO Albert Bourla has stated the